APA (7th ed.) Citation

K, Y., M, A., & R, O. (2026). Postmarketing surveillance study of asciminib in patients with resistant/intolerant chronic myeloid leukemia in Japan. International journal of hematology. https://doi.org/10.1007/s12185-026-04199-x

Chicago Style (17th ed.) Citation

K, Yamaguchi, Aoki M, and Osako R. "Postmarketing Surveillance Study of Asciminib in Patients with Resistant/intolerant Chronic Myeloid Leukemia in Japan." International Journal of Hematology 2026. https://doi.org/10.1007/s12185-026-04199-x.

MLA (9th ed.) Citation

K, Yamaguchi, et al. "Postmarketing Surveillance Study of Asciminib in Patients with Resistant/intolerant Chronic Myeloid Leukemia in Japan." International Journal of Hematology, 2026, https://doi.org/10.1007/s12185-026-04199-x.